All posts by dam_admin

Improving the UK’s performance on survival after cardiac arrest

Improving the UK’s performance on survival after cardiac arrest

We thank Malhotra and Rakhit [1] for their observations of the challenges and potential beneficial outcomes in the management of out-of-hospital cardiac arrest. Clearly, prevention is the best course of action and therefore the promotion of greater awareness of the prodromal symptoms and signs that may precede a cardiac arrest and when to call for help is paramount. If and when a cardiac arrest does occur, survival rates will be greater if this occurs when the ambulance is already on scene after an early call for help. These actions need to be combined with improved levels of bystander cardiopulmonary resuscitation (CPR) and reduced times to defibrillation for all victims of cardiac arrest.

Read more… Improving the UK’s performance on survival after cardiac arrest

High incidence of acute coronary occlusion in patients without protocol positive ST segment elevation referred to an open access primary angioplasty programme

High incidence of acute coronary occlusion in patients without protocol positive ST segment elevation referred to an open access primary angioplasty programme

Background:
Primary percutaneous coronary intervention (PPCI) programmes vary in admission criteria from open referral to acceptance of electrocardiogram (ECG) protocol positive patients only. Rigid criteria may result in some patients with acutely occluded coronary arteries not receiving timely reperfusion therapy.

Big Pharma Harms Patients for Profit but Doctors Must Also Share the Blame

Earlier this week, the government’s chief medical officer Professor Dame Sally Davis created headlines by announcing that the threat to our health posed by antibiotic resistance was on a level comparable to global terrorism. She suggested greater government collaboration to financially incentivise Big Pharma to produce newer, more effective antibiotics. But can we trust the pharmaceutical industry to deliver? Unfortunately their recent track record suggests we cannot.

Read more… Big Pharma Harms Patients for Profit but Doctors Must Also Share the Blame